Fundraising FoxLadderbio (1)
Blue Bell, US · 3 known investors
Find your way into Ladderbio (1)
Sign up to see every warm intro you have to Ladderbio (1)
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Ladderbio (1) team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Ladder Bio (formerly ThirdLaw Molecular) develops Spiroligomer molecules, a class of synthetic, modular fused-ring compounds designed for highly selective binding to target proteins, along with computational design tools for targeted drug discovery. The platform is aimed at creating therapeutics and diagnostic tests as synthetic alternatives to peptides and antibodies.
Founders & leadership
CS
EH
Investors · 3
Founder mafia
2 people who came through Ladderbio (1) went on to found or lead other companies.
Frequently asked questions
- What does Ladderbio (1) do?
- Ladder Bio (formerly ThirdLaw Molecular) develops Spiroligomer molecules, a class of synthetic, modular fused-ring compounds designed for highly selective binding to target proteins, along with computational design tools for targeted drug discovery. The platform is aimed at creating therapeutics and diagnostic tests as synthetic alternatives to peptides and antibodies.
- Who founded Ladderbio (1)?
- Ladderbio (1) was founded by Christian Schafmeister.
- Who are Ladderbio (1)'s investors?
- Ladderbio (1)'s investors include Medical Excellence Capital, Hatch BioFund, SmartGateVC.
- Where is Ladderbio (1) headquartered?
- Ladderbio (1) is headquartered in Blue Bell, US.